Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Toronto
$27,000.00
Development of CXCR3 PET Tracers for Imaging Activated T Cells in Multiple Sclerosis
EF 2025-26
Résumé
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS), caused by T cell infiltration that leads to damage in the brain and spinal cord. Currently, in vivo imaging of neuroinflammation in MS and related disorders with positron emission tomography (PET) targets translator protein (TSPO); unfortunately, TSPO is broadly expressed across multiple cell types. This project aims to create a new CNS PET tracer that can specifically detect activated T cells by targeting CXCR3, a protein that is highly expressed on these cells in neuroinflammatory conditions. Although several CXCR3-targeting PET tracers have been reported, none have shown sufficient blood-brain barrier (BBB) permeability, which is vital for CNS imaging. AMG487, a small molecule that binds strongly and selectively to CXCR3, will be used as the starting point for tracer development. Its physicochemical properties, including molecular weight, polarity, and lack of hydrogen bond donors, fall close to the known ranges seen in previously validated BBB-permeable PET tracers. A small structural modification to AMG487 also creates a site where carbon-11, a positron-emitting radioisotope, can be introduced. Developing this tracer will involve computer modelling, non-radioactive and radioactive chemical synthesis, in vitro testing in CXCR3-transfected cells, and PET imaging in mouse models of MS, with the goal of designing analogues of AMG487 that are both BBB-permeable and highly selective for CXCR3. If successful, this project will produce the first PET tracer capable of directly visualizing activated T cells in the brain, providing an important tool for early MS diagnosis and monitoring, as well as the evaluation of new and established MS treatment strategies.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
572767
Name
Mahmood Maya
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Development of CXCR3 PET Tracers for Imaging Activated T Cells in Multiple Sclerosis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Amg487; Blood-Brain Barrier; Carbon-11; Cxcr3; Imaging Of Activated T Cells; Multiple Sclerosis; Neuroimaging; Neuroinflammation; Positron Emission Tomography; Radiochemistry
Abstract
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS), caused by T cell infiltration that leads to damage in the brain and spinal cord. Currently, in vivo imaging of neuroinflammation in MS and related disorders with positron emission tomography (PET) targets translator protein (TSPO); unfortunately, TSPO is broadly expressed across multiple cell types. This project aims to create a new CNS PET tracer that can specifically detect activated T cells by targeting CXCR3, a protein that is highly expressed on these cells in neuroinflammatory conditions. Although several CXCR3-targeting PET tracers have been reported, none have shown sufficient blood-brain barrier (BBB) permeability, which is vital for CNS imaging. AMG487, a small molecule that binds strongly and selectively to CXCR3, will be used as the starting point for tracer development. Its physicochemical properties, including molecular weight, polarity, and lack of hydrogen bond donors, fall close to the known ranges seen in previously validated BBB-permeable PET tracers. A small structural modification to AMG487 also creates a site where carbon-11, a positron-emitting radioisotope, can be introduced. Developing this tracer will involve computer modelling, non-radioactive and radioactive chemical synthesis, in vitro testing in CXCR3-transfected cells, and PET imaging in mouse models of MS, with the goal of designing analogues of AMG487 that are both BBB-permeable and highly selective for CXCR3. If successful, this project will produce the first PET tracer capable of directly visualizing activated T cells in the brain, providing an important tool for early MS diagnosis and monitoring, as well as the evaluation of new and established MS treatment strategies.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mahmood, Maya
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~